STOCK ALARM
PRO
SA
PRO
Market
Screener
Charts
Alerts
⌘
K
LON
NYC
Crypto
Pro
Sign In
Free Account
Viridian Therapeutics, Inc.
VRDN
NASDAQ
LOADING
|
|
|
Overview
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
As of
2024
• vs 2023
Annual
Quarterly
Per Share
Revenue/Share
$0.00
-36.6%
Net Income/Share
$-3.98
+25.1%
Operating CF/Share
$-3.42
+16.8%
Free CF/Share
$-3.43
+17.1%
Cash/Share
$10.57
-0.9%
Book Value/Share
$9.89
+0.2%
Tangible Book/Share
$9.89
+0.2%
Equity/Share
$9.89
+0.2%
Interest Debt/Share
$0.36
-30.5%
Valuation
Market Cap
$1.30B
+33.5%
Enterprise Value
$1.22B
+36.9%
P/E Ratio
-4.82
-17.6%
P/S Ratio
4,309.19
+38.8%
P/OCF Ratio
-5.60
-5.8%
P/FCF Ratio
-5.59
-6.1%
P/B Ratio
1.94
-12.1%
P/TB Ratio
1.94
-12.1%
EV/Sales
4,049.26
+42.4%
EV/EBITDA
-4.60
-21.3%
Profitability
Earnings Yield
-20.74%
+14.9%
FCF Yield
-17.89%
+5.8%
ROE
-40.19%
+25.3%
ROIC
-43.02%
+21.4%
Return on Tangible Assets
-36.36%
+25.0%
Capital Allocation
CapEx/OCF
-0.22%
+54.9%
CapEx/Revenue
169.21%
-40.8%
CapEx/Depreciation
0.95
-45.0%
SBC/Revenue
13956.95%
-34.8%
Balance Sheet
Debt/Equity
0.03
-34.0%
Debt/Assets
0.03
-33.8%
Net Debt/EBITDA
0.30
-15.0%
Current Ratio
15.43
-15.5%
Interest Coverage
-98.17x
+28.7%
Income Quality
0.86
+11.1%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$9.53
-0.6%